Table 2 Comparison of patient data with or without intraplaque hemorrhage (IPH)

Age, years

54.9 ± 10.8

53.5 ± 11.9

56.2 ± 9.7

0.336

Sex, Male

67 (82.7%)

16 (88.9%)

51 (81%)

1.000

Height, cm

168.0

167.6 ± 5.9

168.3 ± 6.4

0.787

Weight, kg

69.3 ± 9.5

68.6 ± 8.0

68.7 ± 9.8

0.783

BMI, kg/m²

24.6 ± 2.7

24.5 ± 2.8

24.2 ± 2.8

0.986

SBP, mmHg

141.8 ± 17.2

137.4 ± 15.3

146.7 ± 16.1

0.285

DBP, mmHg

86.7 ± 10.3

84.6 ± 11.6

88.6 ± 9.9

0.254

PP, mmHg

55.1 ± 16.3

52.8 ± 14.5

58.1 ± 15.6

0.683

TP, g/L (64–83)

64.1 ± 4.9

63.1 ± 4.0

64.2 ± 4.7

0.127

Total cholesterol, mmol/L(< 5.2)

3.5 ± 0.7

3.6 ± 0.6

3.4 ± 0.8

0.509

HDL, mmol/L (1.16–1-42)

1.1 ± 0.3

1.1 ± 0.3

1.0 ± 0.3

0.038*

LDL, mmol/L (2.7–3.1)

1.9 ± 0.7

1.9 ± 0.7

1.8 ± 0.7

0.593

Triglycerides, mmol/L (< 1.7)

1.6 ± 1.1

1.6 ± 1.2

1.6 ± 1.0

0.079

Glucose, mmol/L (3.9–6.1)

5.8 ± 1.7

5.2 ± 1.0

6.1 ± 1.6

0.007*

Cystatin C, mg/L (0.63–1.25)

0.93 ± 0.33

0.83 ± 0.18

1.05 ± 0.46

0.040*

Homocysteine (< 20 μmol/L)

11.4 ± 10.0

13.2 ± 15.4

9.9 ± 3.5

0.846

SAA (< 10.0 mg/L)

15.0 ± 36.7

5.4 ± 4.2

13.6 ± 17.0

0.117

Degree of stenosis

 Mild, < 50%

13 (20.97%)

9 (29%)

4 (12.9%)

0.196

 Moderate, 50–70%

21 (33.9%)

11 (35.5%)

10 (32.3%)

 Severe, 70–99%

28 (45.2%)

11 (35.5%)

17 (54.8%)

Plaque Burden

88.8 ± 9.5

86.8 ± 8.0

89.7 ± 10.0

0.09

Smoking

24 (38.7%)

11 (50.0%)

13 (41.9%)

0.561

Drinking

22 (35.5%)

7 (31.8%)

15 (48.4%)

0.228

Hypertension

41 (66.1%)

17 (54.8%)

24 (77.4%)

0.06

Cardiovascular disease

20 (32.3%)

8 (25.8%)

12 (38.7%)

0.227

Hyperlipidemia

16 (25.8%)

7 (22.6%)

9 (29.0%)

0.562

Diabetes

17 (27.4%)

6 (19.4%)

11 (35.5%)

0.155

Hyperuricemia

8 (12.9%)

6 (19.4%)

2 (6.5%)

0.13